AA
VIR icon

ALPS Advisors’s Vir Biotechnology VIR Stock Holding History

ALPS Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-66,109
Closed -$377K – 1087
2025
Q3 		$377K Sell
66,109
-8,441
-11% -$43.2K ﹤0.01% 926
2025
Q2 		$376K Sell
74,550
-28,278
-28% -$152K ﹤0.01% 823
2025
Q1 		$666K Sell
102,828
-8,532
-8% -$75.9K ﹤0.01% 554
2024
Q4 		$817K Buy
+111,360
New +$878K 0.01% 535
2024
Q2 		– Sell
-95,242
Closed -$965K – 1005
2024
Q1 		$965K Buy
95,242
+3,124
+3% +$31.8K 0.01% 493
2023
Q4 		$927K Sell
92,118
-7,001
-7% -$64K 0.01% 500
2023
Q3 		$929K Buy
99,119
+641
+0.7% +$9.14K 0.01% 482
2023
Q2 		$2.42M Buy
98,478
+10,505
+12% +$264K 0.02% 276
2023
Q1 		$2.05M Sell
87,973
-2,239
-2% -$57.3K 0.02% 284
2022
Q4 		$2.28M Buy
90,212
+17,794
+25% +$436K 0.02% 277
2022
Q3 		$1.4M Sell
72,418
-21,126
-23% -$537K 0.01% 372
2022
Q2 		$2.38M Buy
93,544
+78,374
+517% +$1.83M 0.02% 284
2022
Q1 		$390K Buy
+15,170
New +$450K ﹤0.01% 496
2021
Q4 		– Sell
-160,089
Closed -$6.97M – 981
2021
Q3 		$6.97M Sell
160,089
-10,690
-6% -$463K 0.07% 162
2021
Q2 		$8.07M Sell
170,779
-35,637
-17% -$1.62M 0.07% 152
2021
Q1 		$10.6M Sell
206,416
-23,236
-10% -$1.25M 0.1% 143
2020
Q4 		$6.15M Buy
229,652
+67,623
+42% +$2.2M 0.07% 164
2020
Q3 		$5.56M Buy
162,029
+1,202
+0.7% +$51.8K 0.08% 152
2020
Q2 		$6.59M Buy
+160,827
New +$5.4M 0.09% 140

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GP
GSK plc London $602M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

ALPS Advisors's VIR Position: Q4 2025 in Review

ALPS Advisors sold out of Vir Biotechnology (VIR) in Q4 2025, closing a stake of 66,109 shares — an estimated $377K sold.

ALPS Advisors first reported a position in VIR in Q2 2020 and held it in 19 quarters. The position peaked at $10.6M in Q1 2021. 218 funds tracked by Wall St. Rank hold VIR as of Q4 2025.

  • ALPS Advisors reported no remaining Vir Biotechnology position as of Q4 2025 after selling out during the quarter.
  • ALPS Advisors sold 66,109 Vir Biotechnology shares in Q4 2025, an estimated $377K.
  • ALPS Advisors first reported a position in Vir Biotechnology in Q2 2020 and held it in 19 quarters.
  • ALPS Advisors's Vir Biotechnology position peaked at $10.6M in Q1 2021.
  • 218 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2025.

Based on ALPS Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.